Petros Pharmaceuticals, Inc. (PTPI)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Shulman J. David
Employees:
20
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
973-242-0005
Are you looking for this stock instead?
Date | Ratio |
---|---|
2022-12-01 | 1:10 |
Petros Pharmaceuticals, Inc. is based in New York, New York. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED) It also develops and commercializes H100, a patented topical formulation candidate for the. treatment of acute Peyronie's disease.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|